Multiple sclerosis (MS) is a disease marked by focal ... Despite much progress, our understanding of the pathophysiology of MS, and the efficacy of our available treatments, remain inadequate.

The pathophysiology of multiple sclerosis (MS) is characterized by demyelination, which culminates in a reduction in axonal transmission. Axonal and neuronal degeneration seem to be concomitant ...

Brier et al, Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients, Annals of Neurology (2024). DOI: 10.1002/ana.27027 ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Jan 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use of some multiple sclerosis drugs including Teva's ...

ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less ...